Tag: Cardiac metabolism

As an anti-ischemic metabolic agent, trimetazidine is widely used in many countries for the treatment of coronary artery disease. It is primarily prescribed for stable angina pectoris when first-line therapies fail to provide sufficient control or are not tolerated. Its unique mechanism of action focuses on optimizing the heart's energy production rather than altering hemodynamics.

Developed in France in the 1970s, trimetazidine is a metabolic agent used primarily as an add-on treatment for angina pectoris, a condition caused by reduced blood flow to the heart. So, what does trimetazidine do to your body? It works by directly altering cellular energy metabolism, protecting heart tissue from the damaging effects of oxygen deprivation.